|
![]() |
|||
|
||||
OverviewThe increasing incidence of type II diabetes, often in association with cardiovascular disease, constitutes one of the major healthcare challenges of the 21st century. However, physicians can now deploy a wide range of therapeutic agents, singly and in combination, to help lower and stabilise blood sugar levels. Drawing on the expertise of internationally-recognised authorities in their fields, this new volume describes the modes of action of each of these types of treatment and evaluates their effectiveness.In the first section of the book, the authors review the various agents used to manage blood sugar, and the mechanisms by which their therapeutic effect is achieved: stimulating increased secretion of insulin, decreasing insulin resistance, interference with glucose production in the liver and suppression of appetite. The second section of the book deals with the treatment of associated cardiovascular problems in the diabetic patient, including antihypertensive, lipid-lowering, and anti-platelet therapies, as well as the management of other complications associated with diabetes, including polyneuropathy."" Therapeutic Strategies in Diabetes"" reviews the evidence for all of these new treatments, evaluates the potential for new and emerging therapies, and presents an informed view of current recommendations for best-practice management. Full Product DetailsAuthor: N. Schaper , C.D.A. StehouwerPublisher: Clinical Publishing,an imprint of Atlas Medical Publishing Ltd Imprint: Clinical Publishing,an imprint of Atlas Medical Publishing Ltd Dimensions: Width: 17.00cm , Height: 2.50cm , Length: 24.00cm Weight: 0.816kg ISBN: 9781904392873ISBN 10: 1904392873 Pages: 256 Publication Date: 30 September 2009 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsPART I: Metabolic Considerations; 1. Glucose Lowering Therapy, M Evans, R Peter; 2. Insulin analogues, G Bolli; 3. New developments in insulin administration, E Renard; 4. C-peptide, J Wahren, K Ekberg, H Jornvall; 5. Metformin - new uses for an old drug, A Vaag, S Lund; 6. Thiazolidinediones, AJ Gilde, B Staels; 7. Rimonabant: CB-1 blockade and possibilities for glucose and glucose tolerance improvement, L Van Gaal; 8. Incretin hormones & diabetes mellitus, T Vilsboll, FK Knop, CF Deacon, JJ Holst; PART II: Cardiovascular considerations; 9. An overview of current lipid-lowering treatments, JPD Reckless; 10. Statins, niacin and fibrate therapy, M Fisher, F Vissereren; 11. CETP-inhibitors, R Dullaart; 12. Antihypertensive treatment: overview, J McKnight, P Padfield, M Strachan; 13. CE-inhibitors and angiotensin receptor blockers, J Segura, L Ruilope; 14. Antiplatelet therapy in diabetes, JA Colwell; 15. Folic acid complications, C van Guldener, YM Smulders; 16. Treatment of symptomatic diabetic polyneuropathy, AJ Boulton, E Salgami; Abbreviations; General Index.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |